Prostate Cancer Response to Immunotherapy Improved With Combination Therapy – Oncology Nurse Advisor
Oncology Nurse Advisor |
Prostate Cancer Response to Immunotherapy Improved With Combination Therapy
Oncology Nurse Advisor Prostate cancer is typically refractory to immunotherapy because of its ability to simultaneously activate 2 different pathways to evade host immune response, according to results from a recent study. This study also suggested a third mechanism of … |
